VC Funding Digest
Tuesday, September 29, 2026
Covering news from · 3 rounds · 1 news item · aggregated from 4 sources
Venture capital activity on September 28, 2026, saw notable investments across several sectors. A prominent theme emerging from the day's headlines is the continued focus on biotech innovation, with companies like Biossil and MAVI securing significant funding rounds. The "combat-tested" designation suggests a trend towards technologies with proven real-world applications, potentially impacting defense or enterprise solutions.
Funding rounds
Modal Labs#
Modal Labs is reportedly closing in on a $750 million funding round at a $15.75 billion valuation.
Sources:
- TechCrunch — Source: Inference provider Modal Labs closing in on $750M round at $15.75B valuation
Biossil#
Biossil has achieved unicorn status following new financing led by OpenAI.
Sources:
- BetaKit — Biossil hits unicorn status with new OpenAI-led financing
DOD Solution#
DOD Solution raised €1.8 million to scale AI autonomy for unmanned systems.
Sources:
- EU-Startups — Combat-tested in Ukraine, DOD Solution raises €1.8 million to scale AI autonomy for unmanned systems
News & Analysis
Cite this page
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VC Funding Digest — Tuesday, September 29, 2026." VCBacked, September 29, 2026, https://www.vcbacked.co/daily/2026-09-29. Accessed September 29, 2026.
VCBacked. (2026). VC Funding Digest — Tuesday, September 29, 2026. Retrieved September 29, 2026, from https://www.vcbacked.co/daily/2026-09-29
{{cite web |title=VC Funding Digest — Tuesday, September 29, 2026 |url=https://www.vcbacked.co/daily/2026-09-29 |website=VCBacked |access-date=September 29, 2026}}Compiled and summarized per the VCBacked methodology. Source links are unmodified and credited above.